Fertility in Women After Cancer Treatment

Cancer treatment can change fertility in two different ways. Some changes are temporary. Some are permanent. NCI states both plainly, and the difference is rarely obvious in the first months after treatment ends.

Whether your fertility recovers depends on several things at once: the type of treatment, the dose, how long it ran, your age at the time, and how much time has passed since. It also depends on your baseline fertility before any of this began.

That is why "will my periods come back" is not a question with a general answer. It is a question about your regimen and your age. Ask it that way.

The medical name for the main problem is primary ovarian insufficiency, usually shortened to POI. It means the ovaries have stopped working properly, which affects both hormone levels and the function of the follicles that hold eggs.

POI is not always the same as menopause. NCI describes two patterns. Sometimes women diagnosed with POI still ovulate and have irregular or occasional periods after treatment. Other times the damage to the ovaries is permanent, and early menopause follows.

That first pattern has a consequence people are rarely told. Occasional ovulation means pregnancy remains possible even when periods are irregular or absent.

NCI notes that POI symptoms may be more intense than in natural menopause. Natural menopause arrives over years. Treatment-induced POI can arrive over weeks.

The symptoms NCI lists are:

• Trouble concentrating.
• Hot flashes and night sweats.
• Irregular periods, or none at all.
• Joint pain, called arthralgia, and muscle aches.
• Mood swings, feeling sad or irritable.
• Sleep problems.
• Vaginal dryness.
• Loss of libido.

Several of these are also side effects of cancer treatment itself, and of the stress of the year you have had. That overlap is exactly why they get dismissed. Naming POI as a possible cause changes what gets offered.

Vaginal dryness and loss of libido in particular are often left off the list because nobody raises them. They are treatable, and they belong on the agenda of a follow-up visit.

This is the part of POI that matters most and gets discussed least.

NCI states that primary ovarian insufficiency can cause long-term health problems. It names low bone mineral density, osteoporosis, and an increased risk of heart and cardiovascular problems.

Estrogen protects bone and blood vessels. Losing it decades early removes that protection decades early. The practical consequences are concrete:

• Bone density needs measuring, and the result needs acting on.
• Blood pressure, cholesterol and blood sugar need tracking, not assuming.
• Weight-bearing exercise, calcium and vitamin D become long-term matters rather than general advice.

Ask directly who owns this. Cancer follow-up appointments focus on the cancer. Bone and heart risk often sits between the oncologist, the primary care doctor and a gynecologist, and things that sit between people fall through.

Several routes exist, and which apply depends on what was done before treatment and what treatment removed.

If you froze eggs, embryos or ovarian tissue before treatment, those remain available. NCI notes that women who have had ovarian tissue frozen and later placed back in the body have conceived, both with and without assistance.

If the uterus was removed, carrying a pregnancy is no longer possible, though frozen eggs or embryos can still be used with a gestational carrier. If both ovaries were removed but the uterus remains, donor eggs are an option.

If nothing was preserved and the ovaries were not removed, the question becomes whether ovarian function recovers. That is measurable, and a reproductive endocrinologist is the person who measures it.

The questions NCI suggests asking after treatment are specific and worth using word for word:

• What are the chances that people who have this treatment become pregnant in the future?
• If fertility changes are temporary, how long might it take for my fertility to return?
• Should I use a method of birth control after treatment, and if so, for how long?

That third question surprises people, and it is not an oversight.

Fertility can be reduced without being gone. Ovulation can happen without regular periods. Some treatments, and some ongoing medicines, can harm a pregnancy. NCI advises asking your doctor whether birth control is needed after treatment and for how long.

The answer depends on your treatment and on whether you are still taking anything. It is worth getting in writing rather than assuming from how you feel.

If you are taking hormone therapy for breast cancer, the timeline is the problem. These treatments often run for years, and those years may be the ones in which you wanted to have a child.

NCI reports initial results from the POSITIVE clinical trial. Some women treated for breast cancer were able to stop hormone therapy while trying to become pregnant, without raising the short-term risk of the cancer returning.

"Short-term" is the operative phrase. If this is relevant to you, ask how long the trial followed participants and what remains unknown. This is a decision to make with your oncologist, not from a headline.

The specialist titles are worth knowing so you can ask for the right referral. An oncofertility specialist works at the boundary of cancer and reproduction. A reproductive endocrinologist manages hormones and fertility.

Three organizations NCI points to are useful after treatment as well as before. The Oncofertility Consortium runs a clinic finder and connects people with navigators. The Alliance for Fertility Preservation tracks state laws requiring insurance coverage. Livestrong Fertility offers a discount program for qualifying patients.

Ask your cancer center whether it has a patient navigator. NCI notes that a growing number of hospitals run navigator programs that help with fertility resources and financial support.

Try naming three things at the start of the appointment, before the scan results take over the time:

• I want to know whether my ovaries are still working, and how that is measured.
• I want a plan for bone and heart risk, and I want to know who owns it.
• I want to know what my options are for having a child, and who I should see.

That framing tends to produce referrals rather than reassurance. For decisions made before treatment starts, see our page on fertility preservation before treatment. For the wider picture of long-term follow-up care, see survivorship.

• NCI: female fertility and cancer treatment